Per peer-reviewed research from the University of Pennsylvania School of Medicine: HBOT can increase stem-cell production up to 8X after 40 to 60 hours of treatment at 2 ATA. After a single HBOT session stem cells (CD34+) doubled.
Building on the above study:
Tampa, Fla. (Mar. 12, 2009) A study to determine if patients with type 2 diabetes can benefit from a combination of autologous (patient self-donated) stem cell infusions (ASC) and hyperbaric (above the normal air pressure of ) oxygen treatment (HBO) before and after ASC has found "significant benefits" in terms of "improvements in glycemic control" along with "reduced insulin requirements." The combination therapy could decrease type 2 diabetes morbidity and mortality, said the authors, who published their study results in the latest issue of Cell Transplantation (Vol. 17 No.12).
The HHS has approved 13 maladies for treatment with HBOT that can be reimbursed under Medicare / Medicaid. Yet around the world up to 137 maladies are commonly treated by low-cost generic HBOT. There are various class-action suits going on now to have treatments reimbursable for children with cerebral palsy. In the UK a network of volunteer-staffed clinics administer HBOT to kids with CP - kids who would otherwise not be able to walk. They charge $8 per-hour for HBOT. In the USA the UHMS negotiates the rates hospitals charge for HBOT, generally over $1,000 per hour - but US hospitals, under UHMS guidelines, refuse to treat any malady that's "off-label" (i.e. not one of the 13 approved maladies). Fortunately there's a network of freestanding HBOT clinics. MD staffed clinics in the USA charge lots more than $8 p/h, but nowhere close to hospital rates.
Here's a good source for HBOT info.
Building on the above study:
Tampa, Fla. (Mar. 12, 2009) A study to determine if patients with type 2 diabetes can benefit from a combination of autologous (patient self-donated) stem cell infusions (ASC) and hyperbaric (above the normal air pressure of ) oxygen treatment (HBO) before and after ASC has found "significant benefits" in terms of "improvements in glycemic control" along with "reduced insulin requirements." The combination therapy could decrease type 2 diabetes morbidity and mortality, said the authors, who published their study results in the latest issue of Cell Transplantation (Vol. 17 No.12).
The HHS has approved 13 maladies for treatment with HBOT that can be reimbursed under Medicare / Medicaid. Yet around the world up to 137 maladies are commonly treated by low-cost generic HBOT. There are various class-action suits going on now to have treatments reimbursable for children with cerebral palsy. In the UK a network of volunteer-staffed clinics administer HBOT to kids with CP - kids who would otherwise not be able to walk. They charge $8 per-hour for HBOT. In the USA the UHMS negotiates the rates hospitals charge for HBOT, generally over $1,000 per hour - but US hospitals, under UHMS guidelines, refuse to treat any malady that's "off-label" (i.e. not one of the 13 approved maladies). Fortunately there's a network of freestanding HBOT clinics. MD staffed clinics in the USA charge lots more than $8 p/h, but nowhere close to hospital rates.
Here's a good source for HBOT info.
